that are positive and others that are negative for the DC marker, CD11c. By confocal microscopy, we showed that virus antigen was present in CD11c + cells. Infection was productive with increases in virus titers observed by 8 hr p.i. (data not shown). Thus, JHM, like A59, readily infects DCs in vitro.
Immature DCs are critical for antigen uptake whereas mature DCs present antigen to T cells and orchestrate the innate and adaptive immune responses. One explanation for the apparent contradiction between the in vivo and in vitro results described above is that MHV preferentially infects either mature or immature DCs. For this purpose, we infected unfractionated BM-derived DCs with a recombinant JHM that expresses GFP (rJHM.GFP) and analyzed cells by FACS at 9 hr p.i. In this virus, GFP was inserted by targeted recombination into gene 4 of the virus because this gene is not necessary for growth in tissue culture cells or mice. 8 The majority of infected CD11c + cells exhibited high expression of MHC class I and II antigen (data not shown) and of the costimulatory molecule, CD86 ( Figure 1 ), consistent with a mature phenotype. An attenuated strain of JHM, J2.2-V-1, 9 and the A59 strain also preferentially infected mature DCs. However, compared with JHM, A59 infected immature DCs to a greater extent ( Figure 1 ). Further, CD11cprecursor cells present in the DC culture were about 10 times more susceptible to infection with A59 compared with JHM ( Figure 2) .
In order to further determine if JHM directly infects mature DCs or JHM infects immature DCs and induces their subsequent maturation, we separated CD86 hi and CD86 lo DCs by flow cytometric sorting prior to infection with rJHM.GFP. As shown in Figure  3A , CD86 hi cells were about 5-10 times more susceptible to JHM infection than were immature DCs. We also quantified the proportion of GFP + cells, including syncytia, by fluorescent microscopy. Again, the percentage of GFP + cells was approximately 5-10 times higher in CD86 hi than in CD86 lo DCs (data not shown). We also found that CD86 hi DCs produced 10 times more JHM than CD86 lo DCs at the peak of the infection ( Figure  3B ).
MHV receptor CEACAM1a is expressed on DCs, 10 and infection of DCs in vitro is CEACAM1a-dependent. 6 One explanation for the differential infection of mature and immature DCs is that CEACAM1a is expressed at higher levels on CD86 hi cells. However, using anti-CEACAM1a mAb (kindly provided by Dr. K Holmes), we observed equivalent expression of CEACAM-1a on CD86 hi and CD86 lo CD11c + DCs by FACS analysis (data not shown). 
DISCUSSION
Our results show that JHM infects cultured BM-derived DCs, with extensive syncytia formation. However, we could not detect a significant number of infected DCs in infected mice (data not shown). Mature DCs are the major population susceptible to JHM infection. However, the majority of DCs in naïve or infected animals are immature. This preferential infection of mature DCs may explain the low percentage of infected DCs that we observed in infected animals. Some other viruses also preferentially infect mature DCs. For example, mature blood-derived human DCs were infected at a higher level by RSV than were immature cells. 11 Although human CMV preferentially infects immature blood-borne DCs, recent results show that the virus has a tropism for mature Langerhans cells. 12 Although MHV receptor CEACAM1a is expressed on DCs, 6 CEACAM1a in MHV infection of DCs was shown in a previous study, in which the presence of anti-CEACAM1a antibody blocked the process completely. 6 However, JHM may require a second host factor for efficient infection of some cells, as previous studies showed that JHM infected some cell lines less efficiently than A59. 13 Our data also show that A59 more readily infects CD11cprecursor cells and CD86 lo DCs than does JHM. These results suggest that JHM, compared with A59, might be more dependent upon the presence of this putative second factor for infection. This factor might be expressed at low levels on CD86 hi DCs, and even lower level on CD11ccells and CD86 lo DCs.
Collectively, our results suggest that JHM entry into DCs or uncoating after entry might be dependent on a cofactor; endosomal proteases have been implicated in SARS-CoV entry, and MHV entry might also require a similar enzyme.
